Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenues, net:    
Product $ 1,810,385 $ 2,830,040
Recurring 102,842 110,020
Total Net Revenue 1,913,227 2,940,060
Cost of Sales:    
Product 1,008,045 1,306,247
Recurring 30,018 31,032
Total Cost of Sales 1,038,063 1,337,279
Gross Profit 875,164 1,602,781
Operating Expenses:    
Research and development 378,456 426,814
Selling, general and administrative 1,769,693 1,641,819
Depreciation and amortization 9,909 7,977
Total Operating Expenses 2,158,058 2,076,610
Operating loss (1,282,894) (473,829)
Other (Expenses) Income:    
Interest (expense), net (10,353) (16,196)
Total Other (Expenses) (10,353) (16,196)
Loss from Continuing Operations Before Provision for Income Taxes (1,293,247) (490,025)
Provision for Income Taxes 991 625
Net Loss from Continuing Operations (1,294,238) (490,650)
Discontinued Operations:    
Gain from sale of discontinued operations (net of tax) 6,384,871 0
Income from discontinued operations (net of tax) 571,802 610,772
Net Income attributable to common stockholders $ 5,662,435 $ 120,122
Net income (loss) per common share:    
Basic - continuing operations $ (.01) $ 0.00
Basic - discontinued operations .05 0.00
Basic - net income attributable to common stockholders .04 0.00
Diluted - continuing operations (.01) 0.00
Diluted - discontinued operations .05 0.00
Net income attributable to common stockholders $ .04 $ 0.00
Weighted Average Common Shares Outstanding used in computing basic net loss per share 132,774,475 127,054,848
Weighted Average Common Shares Outstanding used in computing diluted net loss per share 133,520,471 129,335,871